Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intradermal Dysport for painful diabetic polyneuropathy
IRCT20130518013364N8Phase 3Completed
- Sponsor
- Shahid Beheshti University of Medical Sciences
- Start
- May 2019
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3 trial of botulinum toxin type A in diabetic polyneuropathy (DPN), sponsored by Shahid Beheshti University of Medical Sciences. Started May 2019; status: completed.
02
Drugs
botulinum toxin type A
03
Conditions
diabetic polyneuropathy (DPN)
Beyond the preview
Go deeper on IRCT20130518013364N8.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20130518013364N8.